The Commercial Team is working closely with a range of our member companies on the future of the Cancer Drugs Fund and the design of value based pricing.
Cancer Drugs Fund
The operation of the Cancer Drugs Fund as it has been rolled out and implemented across the regions in the NHS in England has been closely observed.
View the ABPI response to the Cancer Drugs Fund consultation in the Policy and Parliamentary work section.
Value based pricing
We are also developing proposals on value based pricing, which the Government plans to introduce into the UK from January 2014. Our Working Group was also very involved in the development of the ABPI response to the value based pricing consultation which was issued by the Department of Health.
Value based pricing will cover new medicines and a successor scheme to the current PPRS agreement will also be agreed.
View the ABPI response to the value based pricing consultation in the Policy and Parliamentary work section.